Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron versus meperidine for prevention of post-cesarean shivering under spinal anesthesia
IRCT20170516033992N10Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of granisetron, pethidine and bupivacaine in postanesthetic shivering (PAS) (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Shivering. Started May 2022; status: completed.
02
Drugs
granisetronpethidinebupivacaine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20170516033992N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170516033992N10.